Our Story

Resperate Inc. and its parent company 2breathe Technologies Ltd. pioneers the development of digital therapeutic devices, first the RESPeRATE to lower blood pressure naturally and now for sleeplessness. Our original product, RESPeRATE® is the world’s first FDA-cleared, non-drug hypertension treatment device now used by hundreds of thousands of patients worldwide and featured in the American Heart Association statement on non-pharmacological treatments.

The award-winning 2breathe Sleep Inducer was developed after finding that RESPeRATE users reported dozing off during sessions, and over 90% of them reported improved sleep. We decided to turn the “side effect into a feature” and redesigned RESPeRATE real-time coaching guided-breathing technology into a sleek smartphone powered consumer product to help the millions of healthy individuals suffering sleeplessness. 2breathe sleep inducer was awarded the 2017 CES innovation award in the fitness, health and biotech category.

Soft-Tones Pillow Speaker was originally designed for 2breathe users prospects who feared the guiding tones might wake up their bed partner. Once we received the first prototype we realized that its unique curving design provides a great sound experience for everyone. 

2beathe team receiving CES award 2breathe team receiving CES award

Our Team

CEO of RESPeRATE to lower blood pressure

Erez Gavish

CEO & Co-Founder

Erez is a serial entrepreneur and one of the early pioneers in the field of…

Inventor of RESPeRATE to lower blood pressure

Dr. Benjamin Gavish

Chief Science Officer & Co-Founder

Dr. Gavish is a world-renowned multidisciplinary biophysicist, an active researcher in blood vessels and blood-pressure-related…

Medical Director of RESPeRATE to lower blood pressure

Dr. Rowena Sobczyk, MD

Medical Director

Dr. Rowena, MD. is a family doctor in Atlanta, Georgia. She has over 20 years…

VP Products of RESPeRATE to lower blood pressure

Yazon Zohar

VP Product

Yaron brings years of multidisciplinary experience to lead 2breathe Sleep Inducer app and ecosystem. Yaron,…

COO of RESPeRATE to lower blood pressure

Yossy Roitburd

Director of IT & Operations

Yossy, hold the team record for stability and resourcefulness. This is his second gig with…

VP Production of RESPeRATE to lower blood pressure

Eran Schul

VP Production

Eran, brings his 20 years of experience in consumer electronic space and management of manufacturing…

Lead Developer of RESPeRATE to lower blood pressure

Yasmin Gavish

iOS lead developer

Yasmin is a team leader who simply loves programing. She brings her 6th sense for…


Eli Ben-Yehuda

Customer Service Manager & Head of Content

Eli is a licensed Registered Nurse with 12 years of practice in Oncology and cardiology….

Advisor for RESPeRATE to lower blood pressure

Peter Frishauf


Peter is best known as the founder of Medscape, the leading online portal for physicians…

Technology: The Power of Therapeutic Breathing

The cardiovascular and neurological effects of breathing exercises have been known for centuries. In fact, unaided slow breathing is a key element of relaxation techniques such as meditation and yoga. However,  unaided breathing techniques require training and concentration. Whether it is counting breaths or focusing of the breathing sensation trying to prolong the exhalation on your own requires conscious “decision making” process which elevates sympathetic nervous system activity and therefore less optimal for lowering blood pressure and/or sleep.

So you basically need a personal coach to lead you to perform the therapeutic breathing exercise subliminally, without any effort.  RESPeRATE technology takes advantage of the human body’s natural tendency to follow external rhythms and a patented interactive “feedforward” concept. The technology composes rhythmic guiding tones, in real time, while measuring the user’s individual respiration pattern. By dynamically manipulating and recalculating these personalized tones it guides users into a Therapeutic Zone, subliminally, with almost no conscious effort on the user’s part leading to unprecedented efficacy, ease-of-use, and compliance.

site updated by 2019/06/20